Literature DB >> 18539158

Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells.

Sang Kyum Kim1, Jin Won Yang, Mi Ra Kim, Sang Hee Roh, Hyung Gyun Kim, Kwang Youl Lee, Hye Gwang Jeong, Keon Wook Kang.   

Abstract

Acquired resistance to tamoxifen (TAM) is a serious therapeutic problem in breast cancer patients. In this study, we found that the expressions of anti-oxidant proteins (gamma-glutamylcysteine ligase heavy chain (gamma-GCL h), heme oxygenase-1, thioredoxin and peroxiredoxin1) in TAM-resistant MCF-7 (TAMR-MCF-7) cells were higher than control MCF-7 cells. Molecular analyses using antioxidant response element (ARE)-containing reporters and gel-shift supported the critical role of NF-E2-related factor2 (Nrf2)/ARE in the overexpression of antioxidant proteins in TAMR-MCF-7 cells. Intracellular peroxide production was significantly decreased in TAMR-MCF-7 cells and TAM resistance was partially reversed by Nrf2 siRNA. The basal phosphorylation of extracellular signal-regulated kinase (ERK) and p38 kinase were increased in the TAMR-MCF-7 cells and the inhibition of ERK significantly decreased the activity of minimal ARE reporter and gamma-GCL h protein expression in TAMR-MCF-7 cells. However, exposure of TAMR-MCF-7 cells to 17-beta-estradiol or ICI-182,780 did not significantly change gamma-GCL h expression. These results suggest that the persistent activation of Nrf2/ARE is critical for the enhanced expression of anti-oxidant proteins in TAM-resistant breast cancer cells and the pathway of ERK, but not of estrogen receptor signaling are involved in the up-regulation of Nrf2/ARE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539158     DOI: 10.1016/j.freeradbiomed.2008.05.011

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  58 in total

1.  Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?

Authors:  Tongde Wu; Bryan G Harder; Pak K Wong; Julie E Lang; Donna D Zhang
Journal:  Mol Carcinog       Date:  2014-08-23       Impact factor: 4.784

Review 2.  Overview of peroxiredoxins in oxidant defense and redox regulation.

Authors:  Leslie B Poole; Andrea Hall; Kimberly J Nelson
Journal:  Curr Protoc Toxicol       Date:  2011-08

3.  Protective effect of nectandrin B, a potent AMPK activator on neointima formation: inhibition of Pin1 expression through AMPK activation.

Authors:  Sung Hwan Ki; Jung-Woon Lee; Sung Chul Lim; Tran Thi Hien; Ji Hye Im; Won Keun Oh; Moo Yeol Lee; Young Hyun Ji; Yoon Gyoon Kim; Keon Wook Kang
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

4.  Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.

Authors:  Dongmei Ren; Nicole F Villeneuve; Tao Jiang; Tongde Wu; Alexandria Lau; Henry A Toppin; Donna D Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-04       Impact factor: 11.205

Review 5.  Stress-activated cap'n'collar transcription factors in aging and human disease.

Authors:  Gerasimos P Sykiotis; Dirk Bohmann
Journal:  Sci Signal       Date:  2010-03-09       Impact factor: 8.192

6.  TARGETING THE GENOTOXIC EFFECTS OF ESTROGENS.

Authors:  Monica M Montano; Nirmala Krishnamurthy; Smitha Sripathy
Journal:  Drug Discov Today Dis Mech       Date:  2012

7.  Combination of siRNA-directed gene silencing with epigallocatechin-3-gallate (EGCG) reverses drug resistance in human breast cancer cells.

Authors:  Mohammad Ali Esmaeili
Journal:  J Chem Biol       Date:  2015-08-08

Review 8.  Targeting NRF2 signaling for cancer chemoprevention.

Authors:  Mi-Kyoung Kwak; Thomas W Kensler
Journal:  Toxicol Appl Pharmacol       Date:  2009-09-02       Impact factor: 4.219

Review 9.  Redox regulation in cancer: a double-edged sword with therapeutic potential.

Authors:  Asha Acharya; Ila Das; Des Chandhok; Tapas Saha
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

Review 10.  MiRNAs-mediated cisplatin resistance in breast cancer.

Authors:  Xiu Chen; Peng Lu; Ying Wu; Dan-Dan Wang; Siying Zhou; Su-Jin Yang; Hong-Yu Shen; Xiao-Hui Zhang; Jian-Hua Zhao; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.